AIP
JAZZ icon

Ameritas Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ameritas Investment Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12M Buy
11,194
+58
+0.5% +$10.1K 0.07% 330
2025
Q4 		$1.89M Sell
11,136
-235
-2% -$36K 0.06% 356
2025
Q3 		$1.5M Sell
11,371
-599
-5% -$71.8K 0.05% 437
2025
Q2 		$1.27M Buy
11,970
+75
+0.6% +$8.15K 0.04% 534
2025
Q1 		$1.48M Sell
11,895
-214
-2% -$27.9K 0.05% 444
2024
Q4 		$1.49M Sell
12,109
-561
-4% -$66.1K 0.05% 471
2024
Q3 		$1.41M Sell
12,670
-739
-6% -$81K 0.05% 501
2024
Q2 		$1.43M Sell
13,409
-492
-4% -$54.1K 0.05% 456
2024
Q1 		$1.67M Hold
13,901
– – 0.06% 409
2023
Q4 		$1.71M Sell
13,901
-259
-2% -$32.3K 0.06% 362
2023
Q3 		$1.83M Sell
14,160
-1,870
-12% -$249K 0.07% 292
2023
Q2 		$1.99M Hold
16,030
– – 0.07% 296
2023
Q1 		$2.35M Sell
16,030
-266
-2% -$39.3K 0.09% 232
2022
Q4 		$2.53M Buy
16,296
+176
+1% +$25.8K 0.1% 211
2022
Q3 		$2.15M Sell
16,120
-500
-3% -$76K 0.1% 207
2022
Q2 		$2.59M Buy
16,620
+184
+1% +$28.3K 0.11% 170
2022
Q1 		$2.56M Hold
16,436
– – 0.09% 234
2021
Q4 		$2.09M Buy
16,436
+192
+1% +$25.2K 0.07% 315
2021
Q3 		$2.12M Hold
16,244
– – 0.08% 285
2021
Q2 		$2.89M Buy
16,244
+746
+5% +$129K 0.1% 198
2021
Q1 		$2.55M Buy
15,498
+100
+0.6% +$16.5K 0.1% 225
2020
Q4 		$2.54M Sell
15,398
-303
-2% -$45.1K 0.12% 199
2020
Q3 		$2.24M Buy
+15,701
New +$1.95M 0.1% 199

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameritas Investment Partners's JAZZ Position: Q1 2026 in Review

Ameritas Investment Partners increased its Jazz Pharmaceuticals (JAZZ) stake by 0.52% in Q1 2026, buying an estimated $10.1K and bringing the position to 11,194 shares worth $2.12M. The position accounts for 0.07% of the portfolio, ranked #330.

Ameritas Investment Partners first reported a position in JAZZ in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.89M in Q2 2021. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Ameritas Investment Partners held 11,194 shares of Jazz Pharmaceuticals worth $2.12M as of Q1 2026.
  • Ameritas Investment Partners bought 58 Jazz Pharmaceuticals shares in Q1 2026, an estimated $10.1K.
  • Jazz Pharmaceuticals made up 0.07% of Ameritas Investment Partners's portfolio in Q1 2026, its #330 holding.
  • Ameritas Investment Partners first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • Ameritas Investment Partners's Jazz Pharmaceuticals position peaked at $2.89M in Q2 2021.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.